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Differences betweenmales and females are normally
attributed to developmental and hormonal differ-
ences between the sexes. Here, we demonstrate
differences between males and females in gene
silencing using a heterochromatin-sensitive reporter
gene. Using ‘‘sex-reversal’’ mouse models with
varying sex chromosome complements, we found
that this differential gene silencing was determined
by X chromosome complement, rather than sex.
Genome-wide transcription profiling showed that
the expression of hundreds of autosomal genes
was also sensitive to sex chromosome complement.
These genome-wide analyses also uncovered a role
for Sry in modulating autosomal gene expression in
a sex chromosome complement-specific manner.
The identification of this additional layer in the estab-
lishment of sexual dimorphisms has implications for
understanding sexual dimorphisms in physiology
and disease.
INTRODUCTION
Sexual dimorphisms are present in all species and include
physiological and behavioral traits, as well as differences in the
prevalence and course of many common diseases. The under-
lying causes are likely to be dominated by gene expression
differences in developing and adult tissues. Such differences
have recently been shown to be more widespread than previ-
ously anticipated, with more than half of the genes in a given
tissue differentially expressed between the sexes (Yang et al.,
2006). These differences, the majority less than 1.2-fold, are
generally assumed to be mediated by distinct sex hormonal
factors, but genetic factors might also be involved (Ober et al.,
2008; Arnold, 2004). Previous reports could not distinguish
between ‘‘all cells’’ of a given heterogeneous population down-
regulating the affected genes equally, or stochastic effectsDevelopmenresulting in profound changes in expression in a proportion of
cells as seen in position effect variegation (PEV). The modest
expression differences observed between the sexes might
therefore reflect differences in variegation of endogenous genes,
and such ‘‘all-or-nothing’’ effects could have profound biological
effects. Mechanisms whereby such factors confer these sexual
dimorphisms are still not entirely clear, but the importance of
epigenetic regulation has recently been raised (Kaminsky et al.,
2006; Liu et al., 2005). Here, we have uncovered differences
in heterochromatic gene silencing between males and females
in mice and found that they are caused by the difference in
X chromosome complement, rather than sex. In addition, gene
expression profiling uncovered genome-wide effects of the sex
chromosome complement on autosomal gene expression and
revealed a modulatory role for Sry in autosomal gene expression
in a nongonadal tissue.RESULTS
Sexual Dimorphism in Heterochromatic Gene Silencing
Is Caused by X Chromosome Complement
We took advantage of the archetypal epigenetic paradigm
provided by position effect variegation (PEV), a phenomenon
instrumental in the recent revival in epigenetic research
(Jenuwein and Allis, 2001; Lachner et al., 2001; Nielsen et al.,
2001; Rea et al., 2000). In classical PEV, euchromatic genes
are silenced in a proportion of cells because they are translo-
cated close to heterochromatic regions (Weiler and Wakimoto,
1995). We have previously established an in vivo model for
studying PEV in mammals that is based on the integration of a
human CD2 (hCD2) transgene in mouse pericentromeric hetero-
chromatin of chromosome 18, resulting in variegated expression
of the transgene in T cells (Festenstein et al., 1996, 1999). This
‘‘reporter’’ line (hCD2-1.3b) is sensitive to heterochromatic
proteins in a dosage-dependent manner (Festenstein et al.,
1999) and provides a valuable tool for studying the role of factors
that regulate heterochromatic gene silencing (Hiragami-Hamada
et al., 2009).
Strikingly, in flow cytometric analysis of hCD2 levels, we




Figure 1. Sexual Dimorphism in Gene
Silencing Due to X Chromosome Comple-
ment
(A) Typical flow cytometric analysis plots for male
(top panel) and female (bottom panel) peripheral
T lymphocytes. The ‘‘silent’’ (hCD2-negative) pop-
ulation, left of the dividing line, is larger in males
(27.2%) than in females (16.4%).
(B–D) Scatter plots showing the results of flow
cytometric analysis of the proportion of transgenic
cells that repress the hCD2 transgene. Each point
represents the result obtained from a single
transgenic mouse. (B) Males silence more than
females. The proportion of hCD2-negative cells
is higher in males than in females. (C) Sex chromo-
some complement, not sex, determines extent
of silencing. The proportion of hCD2-negative
cells is lower in mice with two X chromosomes
than in mice with an X and Y chromosome,
irrespective of sex. (D) X chromosome comple-
ment determines the extent of silencing. The
proportion of hCD2-negative cells is lower in the
presence of the two X chromosomes than in
the presence of one X chromosome, even in the
presence of a Y chromosome.
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Sex Differences Defined by X and Y Rather Than Sexproportion of cells that silence the transgene in peripheral
T lymphocytes (Figures 1A and 1B) and thymocytes (not shown).
In males, the transgene was silenced in a larger proportion of
cells than in females (p < 0.000001, one-way ANOVA), suggest-
ing a difference in the probability of heterochromatic gene
silencing.
In order to determine whether this sex difference in gene
expression was due to sex or genetic factors, we analyzed
hCD2 reporter silencing in mice with varying sex chromosome
complements. In the ‘‘Four Core Genotypes’’ mouse model,
the Y chromosome lacks the endogenous Sry gene (Y chromo-
some), and male development is now dependent on an
autosomally located Sry transgene (De Vries et al., 2002).
Crossing XYsry transgenic males with XX females allowed us
to differentiate between effects that are due to sex from those
that are due to sex chromosome dosage by analyzing hCD2
expression in the offspring, which consisted of XX and XY
females, and XYsry and XXsry males (De Vries et al., 2002).
We found that the extent of silencing was significantly higher in
XY females and XYsry males than in XX females and XXsry478 Developmental Cell 19, 477–484, September 14, 2010 ª2010 Elsevier Inc.males (p < 0.000001), whereas sex differ-
ences had no significant effect in two-way
ANOVA (Figure 1C). This indicated that
sex chromosome complement rather
than sex determined the extent of hetero-
chromatic silencing of the reporter gene,
with two X chromosomes correlating
with less silencing and the XY chromo-
somal complement resulting in more
silencing.
To differentiate between the relative
contribution of the X and Y chromosomes
to the difference in silencing between
males and females, we studied hCD2
variegation inmales with an XXY complement, where the Y chro-
mosome is attached to one of the two X chromosomes
(Burgoyne et al., 1998; Eicher et al., 1991). Comparison between
such XXY

males and female litter mates with only a single
X chromosome (XO) enabled us to discriminate between a role
for the second X in reduced silencing, and a potential role
for the Y chromosome in increased silencing. We found that
XXY

males silenced the hCD2 transgene significantly less
(p < 0.000001, one-way ANOVA) than XO females (Figure 1D),
which independently confirmed that the sex chromosome
complement rather than sex underlies the difference in trans-
gene silencing. Also, the presence of two X chromosomes
correlated with decreased silencing, even in the presence of
a Y chromosome. This implies that the difference in X chromo-
some complement, rather than the presence or absence of the
Y chromosome, determines the extent of gene silencing.
Altogether, our data suggest the existence of sexual dimorphism
in heterochromatic gene silencing caused by the difference in




Figure 2. The Sex Chromosome Complement Regulates Endogenous Gene Expression
(A) Venn diagram showing the overlap between genes differentially expressed (>1.2-fold, Student’s t test p < 0.05) between XXsry males and XYsry males
(black), and between XX females and XY females (white). This identified 369 genes (yellow) that are sensitive to X chromosome dosage in both males and
females. Lists of the genes corresponding to those indicated in the Venn diagram are given in Table S2.
(B) Histograms showing the percentage of genes that are downregulated in thymus from HP1beta overexpressing XX female mice. Sex complement sensitive
genes show a 4-fold enrichment of HP1beta sensitive genes compared to the T cell transcriptome (p = 0.000001, Fisher’s exact test of overrepresentation).
(C) Density plot of global gene and transcript expression (probe set level) comparing XXsry males with XYsry males. Colored probes reflect the autosomal 369
genes (red) and sexually dimorphic X- and Y-linked genes (green). Most autosomal sex chromosome complement-sensitive genes are expressed higher in XXsry
males than in XYsry males. Note that expression levels in plots are log2. Black line indicates fold change of 1 (no difference).
(D) As in (C), but comparing XX females with XY females. Most autosomal sex chromosome complement-sensitive genes are expressed higher in XY females
than in XX females.
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Sex Differences Defined by X and Y Rather Than SexDefining a Set of Genes Influenced by Sex Chromosome
Complement
In addition to heterochromatic effects, we next wanted to deter-
mine whether the sex chromosome complement also affects
genome-wide autosomal gene expression, and we performed
microarray transcription profiling on thymus RNA isolated from
three biological replicates for each of the Four Core Genotypes.
Previous reports using >360 XX and XY mice suggest that mostDevelopmensexual dimorphisms are modest, with over 70% of genes
showing less than a 1.2-fold difference in transcript levels
(Yang et al., 2006). Interestingly, the fold-difference in expression
of hCD2 seen here was of the same magnitude (Figure 1A, the
ratio of the percentage of hCD2-positive cells between XX and
XY mice was 84/73 = 1.15). We therefore focused on transcripts
that showed fold-changes equal or larger than 1.2-fold with
p < 0.05 (Student’s t test, Shi et al., 2008). Using this approach,tal Cell 19, 477–484, September 14, 2010 ª2010 Elsevier Inc. 479
A B
C D
Figure 3. Sry and/or Sex Modulates Gene Expression in a Sex Chromosome-Specific Manner
(A) Density plot of global gene and transcript expression (probe set level) comparing XYsry males with XY females. Colored probes reflect the autosomal 369
genes (red) and sexually dimorphic X- and Y-linked genes (green). Most autosomal sex chromosome complement-sensitive genes are highly sensitive to Sry/sex
in the presence of an XY sex chromosome complement, and expressed higher in XY females than in XYsrymales. Note that expression levels in plots are log2.
Black line indicates fold change of 1 (no difference).
(B) As in (A), but looking at Sry effect in mice with an XX sex chromosome complement. In contrast to XY background, Sry has little effect on expression of sex
chromosome complement-sensitive genes in the presence of two X chromosomes.
(C) Venn diagram showing the overlap between genes sensitive to sex chromosome complement in males and females (yellow, identified in Figure 2A) and genes
showing sexual dimorphic gene expression between XX females and XYsry males (gray). This identified 175 sexually dimorphic autosomal genes that are regu-
lated by sex chromosome complement (blue). Lists of the genes corresponding to those indicated in the Venn diagram are given in Table S2.
(D) As in (A), but comparing XX females with XYsry males. Most autosomal sex chromosome complement-sensitive genes are higher in XX females than
in XYsry males.
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Sex Differences Defined by X and Y Rather Than Sexwe found 1038 autosomal genes that were differentially
expressed in XYsry males and XXsry males (Figure 2A, black).
As these mice are both males but differ in their sex chromosome
complement, this difference in gene expression can be attrib-
uted to the difference in sex chromosome complement. Simi-
larly, we found 1218 autosomal genes that were different
between XX and XY females (Figure 2A, white), 369 of which
were affected by sex chromosome complement in both males480 Developmental Cell 19, 477–484, September 14, 2010 ª2010 Elsand females (yellow). We will focus on this ‘‘sex chromosome
complement-sensitive set’’ of 369 autosomal genes (SCS) from
here on. Gene ontology analysis revealed that many of the differ-
entially expressed genes are involved in regulation of gene
expression and RNA processing including splicing (see Table S1
available online), and metabolic processes were also shown to
be significantly enriched, accounting for 30% of enriched genes.
Importantly, analysis of enriched pathways (Table S1) revealedevier Inc.
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Sex Differences Defined by X and Y Rather Than Sexseveral that play key roles in T cell biology (including Jak-STAT
and mTOR), indicating that biologically relevant genes and path-
ways are affected by differences in X chromosome dosage, and
such sexual dimorphisms in expression could potentially lead to
variations in physiology and predisposition to disease.
Silencing of the hCD2 reporter is highly sensitive to hetero-
chromatin and heterochromatin proteins such as HP1 (Festen-
stein et al., 1999). Also, Drosophila HP1 is thought to have
a role in sex-specific gene regulation, and loss of HP1 results
in sex-biased lethality (Liu et al., 2005). To examine whether,
similar to hCD2, sensitivity to sex chromosome complement is
linked to heterochromatin, we asked whether the sex chromo-
some sensitive set of 369 autosomal genes were also sensitive
to HP1 in transcription profiling of HP1beta homozygous trans-
genic XX female thymus tissue. In order to facilitate the detection
of downregulated genes, we chose females because within the
hCD2 paradigm expression levels are higher in the presence
of two X chromosomes. Indeed, we found that this group is
enriched for genes that are downregulated upon overexpression
of HP1beta in the thymus (Figure 2B) (p = 0.000001), providing
a link between heterochromatin and sensitivity to sex chromo-
some complement in mammals.
We next examined expression levels for the SCS genes,
comparing mice of the same sex but different sex chromosome
dosage. Most of these genes were expressed at higher levels in
XXsry males than in XYsry males (Figure 2C), despite the males
having the same levels of testosterone (Gatewood et al., 2006).
This result would seem to be concordant with the hCD2 studies
above, which showed that reporter silencing is less likely in the
presence of two X chromosomes. However, comparing XX and
XY females gave the opposite result (Figure 2D), such that in
females, it appears that the presence of the two Xs has a repres-
sive effect, and/or that the presence of a Y chromosome (albeit
lacking Sry) has a positive influence. It therefore seems that
this gene set responds to diverse sex chromosomal regulatory
inputs, some of which are distinct from the reporter silencing
phenomena discussed above.
Sry Modulates Endogenous Gene Expression in a Sex
Chromosome-Specific Manner
Given the opposite effect of sex chromosome complement in
males (+ Sry) and females ( Sry), we examined the effects of
Sry by comparing males and females with equal sex chromo-
some complements. Indeed, expression of 80% of the 369
SCS autosomal genes was significantly higher (p < 0.05; >1.2
fold) in XY females than in XYsry males (Figure 3A), suggesting
a repressive role for Sry/sex in the expression of sex chromo-
some complement-sensitive genes. Interestingly, the repressive
effect of Sry was absent in mice with an XX complement
(Figure 3B), suggesting an interdependence between Sry and
the normal male (XY) sex chromosome complement. Thus, regu-
lation by both Sry and by sex chromosome complement appears
to converge on a subset of genes that are sexually dimorphic in
their expression.
To determine whether the combined effects of sex chromo-
some complement differences and Sry/sex contribute to gene
expression differences between male and female, we directly
compared the SCS genes with autosomal genes that are sexu-
ally dimorphic in expression levels between XX females andDevelopmenXYsry males (Figure 3C). We found that of the 1751 sexually
dimorphic genes (gray) 175 (10%) are also sensitive to the sex
chromosome complement in males and females (blue), with an
additional 401 (23%) sensitive in either males or females (not
shown). Here, the combined effects of sex chromosome
complement and Sry led to generally higher expression in XX
females than in XYsry males (Figure 3D), although this differ-
ence was not significant for all genes. Thus, the sex chromo-
some complement underlies a substantial fraction of gene




Is X Chromosome Complement-Sensitive
We have identified differences between males and females in
heterochromatic gene silencing as exemplified by a murine
model for PEV. Interestingly, we show that this difference in
gene expression is caused by differences in X chromosome
complement, rather than sex.
Exactly how X chromosome complement causes such differ-
ential silencing is unclear at present, but we can envisage several
potential mechanisms. One is that an X-linked gene that is differ-
entially expressed between males and females may be respon-
sible for the observed difference. Such a gene might act as
a chromatin modifier or transcription factor and, for example,
regulate the expression of a gene that is involved in chromatin
metabolism. Although most X-linked genes in females are
silenced on one of the X chromosomes by X-inactivation, there
are genes that escape X-inactivation and are expressed from
both X chromosomes (Carrel and Willard, 2005) and thus are
expected to be differentially expressed between males and
females; such a gene would have to be one of the genes
escaping X inactivation in T cells or their progenitors. Interest-
ingly, two known escapees from X inactivation, Utx (ubiquitously
transcribed tetratricopeptide repeat gene on X chromosome)
and Jarid1c that encode histone demethylases, were recently
shown to be expressed at a higher level in female than in male
brain; this could not be compensated by their Y chromosome
counterparts Uty and Jarid1d (Xu et al., 2008a, 2008b), suggest-
ing the existence of unbalanced gene expression of chromatin
modifiers from sex chromosomes. A possible explanation is
that one or more genes on the X chromosome are differentially
expressed during the brief period before random X inactivation
where both X chromosomes are active (Mak et al., 2004; Oka-
moto et al., 2004). Finally, in Drosophila, the Y chromosome is
thought tomodify PEV by acting as a heterochromatin sink (Dimi-
tri and Pisano, 1989). By analogy, the inactivated X chromosome
in mammals could possibly act as a sink for heterochromatic
factors such as HP1 (Chadwick and Willard, 2003), thereby
reducing the availability of factors required for gene silencing
at other heterochromatic loci.
SRY Interacts with Sex Chromosome Complement
to Modulate Autosomal Gene Expression
Having found a difference in heterochromatin-mediated
silencing dependent on sex chromosome complement, we
went on to identify a subset of several hundred autosomal genestal Cell 19, 477–484, September 14, 2010 ª2010 Elsevier Inc. 481
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with the heterochromatin-sensitive reporter, this SCS population
was enriched for genes that are sensitive to HP1 which is a key
modifier of PEV in mice (Festenstein et al., 1999) and Drosophila
(Eissenberg et al., 1992). This suggests a potentially similar
mechanism underlying these observations. However, there are
also interesting differences between the hCD2 gene and the
autosomal genes in their response to the sex-chromosome
complement. In the case of hCD2, two X chromosomes are
associated with increased expression, whereas, for the auto-
somal sex chromosome complement-sensitive genes, expres-
sion was in most cases higher in XY females compared with
XX females. This could be due to a repressive effect of the two
X chromosomes and/or the presence of the Y chromosome
promoting expression; further experiments are needed to
differentiate between these possibilities.
Sry has amodulatory effect on the expression of the SCS gene
population that is markedly dependent on the sex chromosome
complement (Figures 3A and 3B). Of relevance to the situation in
normal males and females, the addition of Sry to the XY
complement markedly downregulates expression of the majority
of the SCS genes leading to an almost complete balancing
of the expression levels relative to XX females. Our results
therefore suggest a ‘‘compensatory’’ role for Sry in balancing
the expression of sex chromosome complement-sensitive
genes between males and females. Such a compensatory effect
for Sry is consistent with an evolutionary hypothesis recently
elaborated by De Vries (2004) to explain sexual dimorphisms
that may be dependent on the sex chromosome complement.
Interestingly, we found that hCD2 gene expression was not
sensitive to SRY. This might be expected as it is does not
variegate in its normal context and therefore would not have
been under obvious evolutionary pressure to evolve such a
response.
Could Sry regulate expression of SCS genes by a direct
effect of SRY on transcription? The SRY protein has been
shown to functionally interact with Transcription Intermediary
Factor 1 beta (Tif1beta, also known as Trim28 or KAP-1) and
HP1 via KRAB-zinc finger proteins in gonadal cells (Oh et al.,
2005; Polanco et al., 2009), providing a link between Sry
and heterochromatic gene regulation. However, although Sry
mRNA was shown to be expressed in several somatic tissues
in humans (Clepet et al., 1993) there is a paucity of data sug-
gesting somatic expression in mice. Indeed, direct SRY target
genes have only been identified in Sertoli and testicular cells
(Bradford et al., 2009; Jin et al., 2007). The effect reported
here is therefore more likely to be mediated by differences in
sex hormones that are induced by the presence of SRY as
a result of its impact on gonad differentiation. Interestingly,
Palaszynski et al. (2005) reported a sexual dimorphism in the
immune response of mice that was dependent on sex chromo-
some complement but which unlike the findings here was only
revealed following gonadectomy, implying a role for hormones
in ‘‘compensating’’ for sex chromosome complement differ-
ences. In contrast, another study showed that following gonad-
ectomy virtually no sex chromosome complement effects on
gene expression in liver were apparent (van Nas et al., 2009).
This is consistent with the hypothesis that sex chromosome
complement effects on gene expression have evolved together482 Developmental Cell 19, 477–484, September 14, 2010 ª2010 Elswith sex and supports the notion that the modulatory effects of
Sry seen here might be mediated via hormonal effects on gene
expression.
Finally, in addition to the effect on gene expression, pericen-
tromeric heterochromatin has important roles in regulation of
chromosome segregation (Grewal and Jia, 2007) and genome
stability (Peng and Karpen, 2008). Therefore, uncompensated
sexual dimorphism in the function of constitutive pericentromeric
heterochromatin has implications for understanding sex differ-
ences in genome stability.
In conclusion, we have identified another layer in the establish-
ment of sexual dimorphism at the level of gene regulation and
heterochromatin that is determined by the sex chromosome
complement rather than sex. Moreover, there is an additional
sex chromosome complement-specific role for the Sry axis in
modulating autosomal gene expression. Such differences in
sex chromosome complement and presence of Sry might
explain sexual dimorphisms in physiology and disease.
EXPERIMENTAL PROCEDURES
Experimental Animals
All mice were bred at the MRC Clinical Sciences Centre or MRC National Insti-
tute for Medical Research at Mill Hill. All necessary ethical approvals from
Imperial College London and UK HomeOffice were in place. For flow cytomet-
ric analysis, hCD2 homozygous transgenic female mice (CBA background,
Festenstein et al., 1996) were crossed to (1) CBA males, resulting in normal
XYmales and XX females, (2) XYsrymales (C57BL/6 background) to generate
the Four Core genotypes XX and XY females, and XYsry and XXsry males
(De Vries et al., 2002), or (3) XY*O males (predominantly random bred MF1
albino background) to produce XXY* males and XO females (Ishikawa et al.,
2003); 6- to 8-week-old offspring were analyzed for hCD2 expression. For
microarray analysis, XYsry males (C57BL/6 background) were mated to
females (C3H background but with fixed C57BL6 X chromosome, P.S.B.
unpublished data) to generate XX and XY females, and XYsry and XXsry
males that are F1 for all autosomes but with C57BL/6 X chromosomes. This
precludes differences due to different X chromosome origins in the offspring,
but although genetically identical, does not rule out the theoretical possibility
that the effects on autosomal gene expression could be restricted to alleles
from either C3H or C57BL6. Heterozygous HP1beta overexpressing lines
(CBA) were previously generated (Festenstein et al., 1999) and crossed to
generate homozygous offspring and wild-type littermates. Thymus tissue for
all experiments was isolated from 7- to 8-week-old littermates. PCR genotyp-
ing for the presence or absence of the Y chromosome in the Four Core geno-
types was done on DNA isolated from ear punches as described previously
(Turner et al., 2000).
Flow Cytometric Analysis of hCD2 Expression
Flow cytometric analysis of hCD2 expression was performed as described
previously (Festenstein et al., 1996). In brief, 50–100 ml peripheral blood was
obtained from mouse tail veins in heparin and washed in ice-cold PBS, and
pellets were incubated on ice for 45 min in 50 ml phosphate-buffered saline
(PBS) with 1% w/v BSA (PBA) containing fluorescein isothiocyanate conju-
gated mouse anti-humanCD2 (Caltag, 1:50 dilution), R-phycoerythrin conju-
gated rat anti-mouseCD4 (BD PharMingen, 1:100), and tri-color conjugated
rat anti-mouseCD8-TC (BD PharMingen, 1:50). After staining, the samples
were washed with PBS, and red blood cells were lysed with 2.5 ml prewarmed
Gey’s solution (recipe available upon request) for 5 min in a 37C water
bath. Following lysis, the samples were washed in PBS and cell pellets were
resuspended in PBS. The samples were analyzed on a Becton Dickinson
flow cytometer using CellQuest software. A minimal of 20,000 live CD4+
single positive T cells were analyzed for each sample. For statistical analysis,
percentages were converted to angles, followed by ANOVA using the followed
by Generalized Linear Model of the NCSS statistical analysis software (NCSS,
LLC, Kaysville, UT).evier Inc.
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Thymuses were homogenized in 5 ml of ice-cold 3 M LiCl-6 M Urea using an
Ultra Turrax homogenizer (IKA Labortechnik). Samples were sonicated on
ice for 90 s and RNA was precipitated overnight at 4C. After centrifugation,
pellets were washed once in ice-cold 3M LiCl, 6 M Urea and resuspended in
10 mM Tris, 1 mM EDTA, and 0.5% SDS, and RNA was extracted using
phenol/chloroform 5:1 (Sigma). After extraction, total RNA was salt precipi-
tated from the supernatant with the addition of 1/10 volume of 3 M ammonium
acetate and 2.5 volumes of 100% ethanol, washed with ice-cold 70% ethanol,
and resuspended in 50 ml of RNase-free water. The concentration of total RNA
was measured by nanodrop, and quality was assessed on a Bioanalyzer
(Agilent). cRNA of three biological replicates for all Four Core Genotypes, as
well as three HP1beta homozygous and wild-type littermates, was prepared
from 10 mg total RNA using a one-cycle labeling protocol following Affymetrix
instructions. Fragmentation of antisense cRNA and hybridization to Affymetrix
mouse genome 430 2.0 arrays was performed at the CSC/IC Microarray
Centre according to the manufacturer’s instructions. Further details are avail-
able from the CSC/IC Microarray Centre web site (microarray.csc.mrc.ac.uk).
Raw hybridization output files (.CEL) were imported into the R statistical anal-
ysis suite for downstream analysis. Preprocessing using the RMA bioconduc-
tor package was followed by analysis of differentially expressed genes, and
gene selections were exported to spreadsheet software. Genes that showed
fold-changes equal or larger than 1.2-fold with a p < 0.05 (Student’s t test)
were considered differentially expressed (Shi et al., 2008). Sensitivity to sex
chromosome complement and Sry/sex was validated for a selection of genes
by quantitative RT-PCR (Figure S1). Gene ontology and KEGG pathways were
analyzed using DAVID software (http://david.abcc.ncifcrf.gov/). Comparisons
were made between the 369 sex chromosome sensitive genes (Figure 2A) and
all genes expressed in thymus as identified by Affymetrix MAS5.0 absent/
present calls. Genes falling into categories described in Venn diagrams are
listed in Table S2. All Affymetrix data have been deposited in NCBI’s Gene
Expression Omnibus (Edgar et al., 2002) and are accessible through GEO
Series accession number GSE21822.SUPPLEMENTAL INFORMATION
Supplemental Information includes one figure and two tables and can be found
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